I'm seeing a lot of big accounts missing the mark on this story. HHS through BARDA is cancelling contracts for mRNA vaccine research related to viral respiratory illnesses. This does not affect mRNA cancer research by NIH and Moderna.

It's still bad news but let's try to keep our facts straight.

Screen grab of a section of the HHS press release which is black text on white background. 

The wind-down affects a range of programs including:Termination of contracts with Emory University and Tiba Biotech.De-scoping of mRNA-related work in existing contracts with Luminary Labs, ModeX, and Seqirus.Rejection or cancellation of multiple pre-award solicitations, including proposals from Pfizer, Sanofi Pasteur, CSL Seqirus, Gritstone, and others, as part of BARDA’s Rapid Response Partnership Vehicle (RRPV) and VITAL Hub.Restructuring of collaborations with DoD-JPEO, affecting nucleic acid-based vaccine projects with AAHI, AstraZeneca, HDT Bio, and Moderna/UTMB.
29

Dammit. Now I have to go see if I reposted something that was overly pessimistic. I hate having to correct myself for reposting before confirming.

Replies

  1. It's OK. 'Overly pessimistic' hasn't been getting much face time these days and was probably happy to get out for a minute.

    0